PINX:IMMY Insider Activity 3/A Filing - 1/25/2012

Effective Date 1/25/2012

PINX:IMMY (): Fair Value Estimate
Premium
PINX:IMMY (): Consider Buying
Premium
PINX:IMMY (): Consider Selling
Premium
PINX:IMMY (): Fair Value Uncertainty
Premium
PINX:IMMY (): Economic Moat
Premium
PINX:IMMY (): Stewardship
Premium
 
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Schupp Joachim PH
2. Date of Event Requiring Statement (Month/Day/Year)
01/25/2012
3. Issuer Name and Ticker or Trading Symbol
Imprimis Pharmaceuticals, Inc. [IMMY]
(Last)
(First)
(Middle)
C/O IMPRIMIS PHARMACEUTICALS, INC., 437 SOUTH HIGHWAY 101, SUITE 209
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Medical Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
03/27/2012
(Street)

SOLANA BEACH, CA 92075
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy) 12/15/2011(1) 12/14/2014 Common Stock 2,464 $0.8 D  
Option (Right to Buy) 02/28/2012(2) 02/14/2016 Common Stock 375,000 $0.72(3) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Schupp Joachim PH
C/O IMPRIMIS PHARMACEUTICALS, INC.
437 SOUTH HIGHWAY 101, SUITE 209
SOLANA BEACH, CA 92075
      Chief Medical Officer  

Signatures

Joachim Schupp 05/09/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The stock options, granted on December 15, 2011 with a strike price of $.80 and exercisable immediately upon issuance, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan.
(2) The stock options, granted on February 15, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Dr. Schupp's options vest over a 3 year period at a strike price of $0.72, with 1/36 of the total number of options vesting each monthly period following the grant date of such options. As of the date of this Form 3 filing, options to purchase 41,668 shares of the Issuer's common stock are exercisable, but no options have been exercised.
(3) This amended Form 3 is being filed by Dr. Schupp to amend his original Form 3 filed on March 27, 2012, for the sole purpose of correcting the exercise price of the stock options granted to Dr. Schupp on February 15, 2012 as described in Footnote 2 above from $0.60 to $0.72.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

PINX:IMMY Insider Activity 3/A Filling

PINX:IMMY Stock - Get Insider Activity SEC Filing of PINX:IMMY stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

PINX:IMMY Insider Activity 3/A Filing - 1/25/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: PINX:IMMY Insider Activity 3 Filing - 7/26/2012  |  Next: PINX:IMMY Insider Activity 4 Filing - 4/1/2012